Co-Authors
This is a "connection" page, showing publications co-authored by BRIAN FRANCIS CHAPIN and GREGORY RAVIZZINI.
Connection Strength
0.681
-
Rate of incidental central nervous system meningioma detected in patients undergoing 18F-fluciclovine PET/CT imaging for evaluation of prostate cancer. Nucl Med Commun. 2021 Jul 01; 42(7):755-762.
Score: 0.200
-
The use of PET/CT in prostate cancer. Prostate Cancer Prostatic Dis. 2018 04; 21(1):4-21.
Score: 0.156
-
Interreader and Intrareader Reproducibility of 18F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies. J Nucl Med. 2024 Aug 01; 65(8):1239-1243.
Score: 0.062
-
Reply by Authors. J Urol. 2023 Aug; 210(2):310-311.
Score: 0.058
-
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply. J Urol. 2023 09; 210(3):411-412.
Score: 0.057
-
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). J Urol. 2023 08; 210(2):299-311.
Score: 0.057
-
Imaging Biochemical Recurrence After Prostatectomy: Where Are We Headed? AJR Am J Roentgenol. 2020 06; 214(6):1248-1258.
Score: 0.046
-
Imaging and Management of Prostate Cancer. Semin Ultrasound CT MR. 2020 Apr; 41(2):207-221.
Score: 0.045